LUGPA spotlights AI, clinical advances and practice resilience at annual meeting

LUGPA wrapped up its 18th Annual Meeting in Chicago after three days of sessions on precision medicine, AI, practice management and federal policy for independent urologists. The meeting underscored how physician-led practices are trying to improve care while protecting autonomy and financial stability.

Why it matters: - Independent urology groups are facing pressure from rising administrative demands, changing reimbursement models and fast-moving clinical innovation. - LUGPA’s annual meeting focused on tools and strategies meant to help physician-led practices stay competitive while improving patient care. - The conference also highlighted how policy shifts could affect physician autonomy across the specialty.

What happened: - LUGPA concluded its 18th Annual Meeting on Nov. 7 in Chicago after a three-day conference held Nov. 5-7, 2026. - The meeting drew independent urologists, practice administrators, advanced practice providers and health system executives. - The program covered precision medicine, practical AI integration, practice management and federal healthcare policy. - LUGPA framed the event around clinical innovation and practice sustainability for physician-led medical groups.

The details: - The clinical track, “Precision in Practice,” was co-led by Gordon Brown and Jason Hafron. - Sessions covered PSMA theranostics, PTEN and biomarker integration, non-muscle invasive bladder cancer care models, prostate cancer treatment intensification, neuromodulation, histotripsy and BPH Centers of Excellence. - The Practice Administrators Workshop was chaired by Kirsten Anderson and focused on benchmarking metrics, ancillary revenue, billing and coding, EMR transitions and leadership challenges. - AI sessions examined ambient digital scribes, administrative workflow automation, AI-assisted pathology and diagnostic imaging. - Specialized breakouts addressed research administration, recruitment and clinical trial expansion for clinical research staff, radiation oncology teams, laboratory managers and emerging leaders. - A Nov. 7 keynote, “A Conversation with Chris Christie and David Axelrod,” examined how federal regulatory changes and policy decisions could affect independent physician autonomy. - Jeffrey Spier, LUGPA president, said the group helps translate clinical science and policy into practical solutions for practices. - Spier also pointed to theranostics, advanced prostate cancer clinics, bladder cancer care and AI as examples of areas changing day-to-day practice. - Celeste Kirschner, LUGPA chief executive officer, said the meeting was designed around the priorities of physician-led urology practices nationwide. - LUGPA said the annual meeting created peer-to-peer knowledge sharing that can lead to tangible practice improvements. - The organization said it also offers educational programming, advocacy, operational benchmarking and practice management resources. - LUGPA directs readers to more information on its website.

Between the lines: - The agenda shows independent urology practices are balancing two demands at once: keep up with clinical innovation and tighten operations. - The inclusion of AI, benchmarking and revenue-cycle topics suggests practice survival is now tied as much to workflow efficiency as to medical expertise. - Bringing in national political figures signals that LUGPA sees federal policy as a direct business issue, not just a background concern.

What's next: - LUGPA will likely continue using its annual meeting to push new clinical and operational strategies into physician-led practices. - Independent urology groups are expected to keep focusing on AI adoption, care model changes and practice efficiency as policy and reimbursement pressures evolve. - LUGPA’s broader advocacy and benchmarking work will remain part of its pitch to member practices.

The bottom line: - LUGPA is betting that independent urology can stay viable by pairing cutting-edge clinical education with practical business tools.